Madeleine Johnson

New York

Reporter at GenomeWeb

Editor at 360Dx

MA journalism/PhD neuroscience. Science writer. Tricoteuse, but with crochet. NTA.

Featured in: Favicon

genomeweb.com Favicon

360dx.com

ft.com

entrepreneur.com Favicon

slate.com

boingboing.net Favicon

chicagobusiness.com Favicon

modernhealthcare.com Favicon

spectrumnews.org Favicon

byuiscroll.org + 3 more

Articles

Becton Dickinson Using Diverse Business Against Headwinds as Fiscal Q2 Revenues Rise 5 Percent

1 week ago | 360dx.com | Madeleine Johnson

Get the full story with 360Dx Premium Only $95 for the first 90 days
UPDATE: Becton Dickinson Using Diverse Business Against Headwinds as Fiscal Q2 Revenues Rise 5 Percent

2 weeks ago | genomeweb.com | Madeleine Johnson

This story has been updated to include comments from a call with investors. NEW YORK – Becton Dickinson plans to use its diverse global business to adapt to reduced research funding support, tariffs, and other headwinds as it continues to suss out buyers for its biosciences and diagnostics business, the firm said on Thursday as it also reported its fiscal second quarter financial results.
At AACR Qiagen Emphasizing Oncology With New Products, Expanded Collaborations

2 weeks ago | 360dx.com | Madeleine Johnson

NEW YORK – Qiagen highlighted its evolving plans to further expand its oncology portfolio at the American Association for Cancer Research meeting this week in Chicago, with plans to debut two new sample prep systems and a next-generation sequencing product developed under an expanded collaboration with Myriad Genetics in the coming year.
Baebies' Breakthrough Device Designation Pushes its Multimodal Point-of-Care Testing Closer to Reality

2 weeks ago | genomeweb.com | Madeleine Johnson

NEW YORK – Baebies brought its multimodal diagnostic system one step closer to clinical use this week with the announcement of breakthrough device designation from the US Food and Drug Administration. As part of a strategic shift, the Durham, North Carolina-based firm recently licensed its digital microfluidic newborn screening business and Seeker platform in order to advance commercialization of its Finder platform and is currently focusing on clinical trials for various assays on that platform.
Baebies' Breakthrough Device Designation Pushes its Multimodal Point-of-Care Testing Closer to Reality

2 weeks ago | 360dx.com | Madeleine Johnson

NEW YORK – Baebies brought its multimodal diagnostic system one step closer to clinical use this week with the announcement of breakthrough device designation from the US Food and Drug Administration. As part of a strategic shift, the Durham, North Carolina-based firm recently licensed its digital microfluidic newborn screening business and Seeker platform in order to advance commercialization of its Finder platform and is currently focusing on clinical trials for various assays on that platform.
Low-Cost HIV Molecular Self-Test Advances at Florida Atlantic University

3 weeks ago | 360dx.com | Madeleine Johnson

NEW YORK – Researchers at Florida Atlantic University are progressing on a project to create a highly sensitive molecular diagnostic system for HIV self testing. With their recent Phase II funding only slightly delayed by new National Institutes of Health funding policies, the team expects to soon prototype its disposable microfluidic device on clinical samples as part of its path toward commercialization.
Nuclein Advances Point-of-Care Test Menu for 15-Minute PCR System

1 month ago | 360dx.com | Madeleine Johnson

NEW YORK – Following CLIA waiver for its 15-minute qPCR system and combination COVID/influenza assay earlier this year, diagnostics developer Nuclein is further expanding into the point-of-care testing space with plans to begin clinical trials later this year for two new tests. Nuclein obtained 510(k) and CLIA waiver from the US Food and Drug Administration in January for its DASH system and a multiplex test to detect COVID-19, influenza A, and influenza B infections.
As Digital PCR Expands into Oncology, More Clinical Diagnostic Applications on Horizon

1 month ago | 360dx.com | Madeleine Johnson

NEW YORK – While digital PCR has been around for more than three decades and has established itself as a valuable research tool, its use in clinical diagnostics had continued to be a goal more than a reality.
With FDA Authorization, Visby Medical Aims to Bring Molecular STI Testing to OTC Space

1 month ago | 360dx.com | Madeleine Johnson

NEW YORK – By becoming the first diagnostics developer to achieve regulatory clearance for a fully at-home, over-the-counter molecular test detecting sexually transmitted infections, Visby Medical believes it can pave the way for a new market.
Fables for our times

1 month ago | theamericanmag.com | Madeleine Johnson

Anyone — parents, teachers, policy-makers — who has kept up with the changes U.S. education in the last decade will have noticed the obsession with STEM: science, technology, engineering, and mathematics. STEM was promoted as the cure for everything — everything from rising Chinese power to poverty. This STEM obsession has led to cuts, and sometimes elimination, of courses of study that do not have obvious connections to the job market.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers: 759
Tweets: 3K
DMs Open: No

Madeleine Johnson @tweetMadeleine

25 Oct 24

RT @SCarson_News: An interesting read that published a few weeks ago on Shyamala Harris' story as an immigrant -- "The Woman Who Made Kam…

Madeleine Johnson @tweetMadeleine

24 Oct 24

RT @susanematthews: I love this beautiful essay from @TonyHoWasHere about his weird hobby (searching for graves), how he found it, and what…

Madeleine Johnson @tweetMadeleine

23 Oct 24

RT @jordanacep: The mathematics of 20th-century prodigy Ramanujan was mysterious, otherworldly. I wrote about his life and work for @Quanta…

Madeleine Johnson

Articles

Becton Dickinson Using Diverse Business Against Headwinds as Fiscal Q2 Revenues Rise 5 Percent

UPDATE: Becton Dickinson Using Diverse Business Against Headwinds as Fiscal Q2 Revenues Rise 5 Percent

At AACR Qiagen Emphasizing Oncology With New Products, Expanded Collaborations

Baebies' Breakthrough Device Designation Pushes its Multimodal Point-of-Care Testing Closer to Reality

Baebies' Breakthrough Device Designation Pushes its Multimodal Point-of-Care Testing Closer to Reality

Low-Cost HIV Molecular Self-Test Advances at Florida Atlantic University

Nuclein Advances Point-of-Care Test Menu for 15-Minute PCR System

As Digital PCR Expands into Oncology, More Clinical Diagnostic Applications on Horizon

With FDA Authorization, Visby Medical Aims to Bring Molecular STI Testing to OTC Space

Fables for our times

Contact details

Emails

Socials & Sites

X (formerly Twitter)